Key features of the possible Pfizer Astrazenca bid

The possible $100bn deal would create the world's largest pharmaceutical company Credit: Press Association Images/Dan Kitwood

US pharmaceutical giant Pfizer, maker of Viagra, has made a second attempt to takeover AstraZeneca following a failed attempt back in January.

Here are the key facts and figures of the deal.

Astra accounts for around 2.3 percent of UK exports.
AstraZeneca employs around 7,000 people direcly while supporting a further 30,000 jobs in the UK.
In 2011 the company added £3.8 billion in wealth creation.
Over £1 billion was invested in Research and Development.

Following reports of the renewed bid AstraZeneca's share price soared by 18 per cent in trading earlier hitting a record high of £47.94.

The deal itself would dwarf anything else in the global pharmaceutical industry despite a recent flurry of M&A activity in the sector.

The Potential $100bn deal would create the world's largest pharma company.
If it goes through it would be biggest ever takeover of a UK-listed company.
It would be the biggest deal in the pharma sector since Pfizer’s $111.8bn takeover of Warner-Lambert in 2000.